Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Payal Dhar

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Scientific American|February 18, 2025
Lunar Facelift: An ancient moon melt event may explain a timing mysteryPayal Dhar
ACS Central Science|July 3, 2023
A Conversation with Leo GrossPayal Dhar
ACS Central Science|April 29, 2025
A Conversation with Sambuddha MisraPayal Dhar
Scientific American|December 16, 2025
Ignorosphere Surfers: Little sun-powered fliers could explore Earth's high atmospherePayal Dhar
ACS Central Science|July 3, 2023
Scientists Are Engineering Asphalt That Is Safer for Humans and the EnvironmentPayal Dhar
Nature|March 23, 2023
Octopus and ResearchEquals aim to break the publishing mouldPayal Dhar
Current Opinion in Immunology|March 12, 2018
NKG2D and its ligands in cancerPayal Dhar, Jennifer D Wu
Journal of Clinical Medicine|September 25, 2019
NK Cell Plasticity in CancerSizhe Liu, Payal Dhar, Jennifer D Wu
Journal for Immunotherapy of Cancer|August 27, 2019
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC<sup>+</sup> tumors respond to PD1/PD-L1 blockade therapyJinyu Zhang, Pablo Saenz-Lopez Larrocha, Bin Zhang, et al.
Journal of Hematology & Oncology|June 11, 2020
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapyFahmin Basher, Payal Dhar, Xin Wang, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Scientific American|February 18, 2025
Lunar Facelift: An ancient moon melt event may explain a timing mysteryPayal Dhar
ACS Central Science|July 3, 2023
A Conversation with Leo GrossPayal Dhar
ACS Central Science|April 29, 2025
A Conversation with Sambuddha MisraPayal Dhar
Scientific American|December 16, 2025
Ignorosphere Surfers: Little sun-powered fliers could explore Earth's high atmospherePayal Dhar
ACS Central Science|July 3, 2023
Scientists Are Engineering Asphalt That Is Safer for Humans and the EnvironmentPayal Dhar
Nature|March 23, 2023
Octopus and ResearchEquals aim to break the publishing mouldPayal Dhar
Current Opinion in Immunology|March 12, 2018
NKG2D and its ligands in cancerPayal Dhar, Jennifer D Wu
Journal of Clinical Medicine|September 25, 2019
NK Cell Plasticity in CancerSizhe Liu, Payal Dhar, Jennifer D Wu
Journal for Immunotherapy of Cancer|August 27, 2019
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC<sup>+</sup> tumors respond to PD1/PD-L1 blockade therapyJinyu Zhang, Pablo Saenz-Lopez Larrocha, Bin Zhang, et al.
Journal of Hematology & Oncology|June 11, 2020
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapyFahmin Basher, Payal Dhar, Xin Wang, et al.
Pageof 2